20250213526. Triple Uptake Inhibitor Th (Noema Pharma AG)
Appearance
TRIPLE UPTAKE INHIBITOR FOR THE TREATMENT OF ATYPICAL DEPRESSION
Abstract: provided herein are methods of treating atypical depression in a subject in need thereof by administering to the subject compositions comprising a triple reuptake inhibitor, having the structure of compound (1).
Inventor(s): George Garibaldi
CPC Classification: A61K31/40 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))
Search for rejections for patent application number 20250213526